Collegium Pharma Inc. (coll 2.875 02/15/29)
13F holders, Q4 2025 (December 31)2holders +1
2new positions
0sold out
$4.10avg. 13F price*
At the end of Q4 2025, 2 institutions reported holding Collegium Pharma Inc. (coll 2.875 02/15/29) in their 13F filings, up 1 from Q4 2024. 2 opened new positions and 0 sold out. The largest holders were Boussard & Gavaudan Investment Management LLP ($10.8M) and Picton Mahoney Asset Management ($5.7M).
- Company
- Collegium Pharma Inc. (coll 2.875 02/15/29)
- CUSIP
- 19459JAC8
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $16.4M |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q4 2025: 4,007,500 shares bought, net +4,007,500 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Boussard & Gavaudan Investment Management LLP | 1.63% | New | 7,500 | $10.8M |
| Picton Mahoney Asset Management | 0.06% | New | 4,000,000 | $5.7M |
"% of holder's portfolio" is COLLEGIUM PHARMA INC (COLL 2.875 02/15/29)'s weight in each manager's 13F, not the share of Collegium Pharma Inc. (coll 2.875 02/15/29) the manager owns.